Ameriprise Financial Inc Bluebird Bio, Inc. Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$0.85 - $1.26 $476 - $706
-561 Reduced 0.01%
6,391,637 $6.26 Million
Q1 2024

May 15, 2024
BUY
$0.91 - $1.75 $3.31 Million - $6.36 Million
3,636,498 Added 131.96%
6,392,198 $8.18 Million
Q4 2023

Feb 14, 2024
BUY
$1.32 - $4.83 $598,259 - $2.19 Million
453,227 Added 19.68%
2,755,700 $3.8 Million
Q3 2023

Nov 14, 2023
BUY
$3.02 - $4.05 $6.2 Million - $8.32 Million
2,053,639 Added 825.3%
2,302,473 $7 Million
Q2 2023

Aug 14, 2023
BUY
$2.79 - $5.03 $476,730 - $859,481
170,871 Added 219.17%
248,834 $818,000
Q1 2023

May 15, 2023
BUY
$3.14 - $8.22 $83,998 - $219,893
26,751 Added 52.24%
77,963 $247,000
Q4 2022

Feb 14, 2023
BUY
$5.77 - $8.49 $180,162 - $265,091
31,224 Added 156.21%
51,212 $354,000
Q3 2022

Nov 14, 2022
BUY
$3.75 - $7.39 $74,955 - $147,711
19,988 New
19,988 $126,000
Q3 2021

Nov 15, 2021
SELL
$11.24 - $21.0 $3.86 Million - $7.2 Million
-343,054 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$18.04 - $22.09 $294,917 - $361,127
16,348 Added 5.0%
343,054 $11 Million
Q1 2021

May 17, 2021
BUY
$16.59 - $33.89 $4.79 Million - $9.78 Million
288,517 Added 755.5%
326,706 $9.85 Million
Q4 2020

Feb 12, 2021
SELL
$27.5 - $37.92 $224,812 - $309,996
-8,175 Reduced 17.63%
38,189 $1.65 Million
Q3 2020

Nov 16, 2020
SELL
$34.44 - $43.75 $3.25 Million - $4.13 Million
-94,494 Reduced 67.08%
46,364 $2.5 Million
Q2 2020

Aug 14, 2020
SELL
$27.12 - $45.97 $6.23 Million - $10.6 Million
-229,668 Reduced 61.98%
140,858 $8.6 Million
Q1 2020

May 15, 2020
SELL
$26.16 - $63.5 $263,745 - $640,207
-10,082 Reduced 2.65%
370,526 $17 Million
Q4 2019

Feb 14, 2020
BUY
$46.96 - $61.67 $8.44 Million - $11.1 Million
179,669 Added 89.41%
380,608 $33.4 Million
Q3 2019

Nov 14, 2019
SELL
$59.47 - $93.1 $120,783 - $189,086
-2,031 Reduced 1.0%
200,939 $18.4 Million
Q2 2019

Aug 14, 2019
SELL
$75.84 - $105.21 $661,931 - $918,272
-8,728 Reduced 4.12%
202,970 $25.8 Million
Q1 2019

May 15, 2019
BUY
$64.44 - $104.11 $3.69 Million - $5.96 Million
57,232 Added 37.05%
211,698 $33.3 Million
Q4 2018

Feb 14, 2019
SELL
$59.1 - $93.26 $1.48 Million - $2.33 Million
-25,024 Reduced 13.94%
154,466 $15.3 Million
Q3 2018

Nov 14, 2018
SELL
$88.86 - $117.49 $6.56 Million - $8.68 Million
-73,874 Reduced 29.16%
179,490 $25.6 Million
Q2 2018

Aug 14, 2018
SELL
$99.64 - $127.59 $2.04 Million - $2.61 Million
-20,461 Reduced 7.47%
253,364 $39.8 Million
Q1 2018

May 15, 2018
SELL
$105.8 - $150.94 $8.62 Million - $12.3 Million
-81,432 Reduced 22.92%
273,825 $46.7 Million
Q4 2017

Feb 12, 2018
BUY
$81.25 - $130.7 $1.22 Million - $1.96 Million
14,998 Added 4.41%
355,257 $63.2 Million
Q3 2017

Nov 07, 2017
BUY
$57.74 - $91.42 $19.6 Million - $31.1 Million
340,259
340,259 $46.7 Million

Others Institutions Holding BLUE

# of Institutions
151
Shares Held
63.4M
Call Options Held
264K
Put Options Held
428K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $28.5M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email